SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Gíslason Thorarinn)
 

Search: WFRF:(Gíslason Thorarinn) > (2010-2014) > Nocturnal sweating ...

Nocturnal sweating - a common symptom of obstructive sleep apnoea : the Icelandic sleep apnoea cohort

Arnardottir, Erna Sif (author)
Janson, Christer (author)
Uppsala universitet,Lungmedicin och allergologi
Bjornsdottir, Erla (author)
show more...
Benediktsdottir, Bryndis (author)
Juliusson, Sigurdur (author)
Kuna, Samuel T. (author)
Pack, Allan I. (author)
Gislason, Thorarinn (author)
show less...
 (creator_code:org_t)
2013-05-14
2013
English.
In: BMJ Open. - : BMJ. - 2044-6055. ; 3:5, s. e002795-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objectives: To estimate the prevalence and characteristics of frequent nocturnal sweating in obstructive sleep apnoea (OSA) patients compared with the general population and evaluate the possible changes with positive airway pressure (PAP) treatment. Nocturnal sweating can be very bothersome to the patient and bed partner. Design: Case-control and longitudinal cohort study. Setting: Landspitali-The National University Hospital, Iceland. Participants: The Icelandic Sleep Apnea Cohort consisted of 822 untreated patients with OSA, referred for treatment with PAP. Of these, 700 patients were also assessed at a 2-year follow-up. The control group consisted of 703 randomly selected subjects from the general population. Intervention: PAP therapy in the OSA cohort. Main outcome measures: Subjective reporting of nocturnal sweating on a frequency scale of 1-5: (1) never or very seldom, (2) less than once a week, (3) once to twice a week, (4) 3-5 times a week and (5) every night or almost every night. Full PAP treatment was defined objectively as the use for = 4 h/day and = 5 days/week. Results: Frequent nocturnal sweating (= 3x a week) was reported by 30.6% of male and 33.3% of female OSA patients compared with 9.3% of men and 12.4% of women in the general population (p<0.001). This difference remained significant after adjustment for demographic factors. Nocturnal sweating was related to younger age, cardiovascular disease, hypertension, sleepiness and insomnia symptoms. The prevalence of frequent nocturnal sweating decreased with full PAP treatment (from 33.2% to 11.5%, p<0.003 compared with the change in non-users). Conclusions: The prevalence of frequent nocturnal sweating was threefold higher in untreated OSA patients than in the general population and decreased to general population levels with successful PAP therapy. Practitioners should consider the possibility of OSA in their patients who complain of nocturnal sweating.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • BMJ Open (Search for host publication in LIBRIS)

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view